Страна: САЩ
Език: английски
Източник: NLM (National Library of Medicine)
Erythromycin (UNII: 63937KV33D) (Erythromycin - UNII:63937KV33D)
Teligent Pharma, Inc.
TOPICAL
PRESCRIPTION DRUG
Erythromycin Topical Solution is indicated for the topical treatment of acne vulgaris. Erythromycin Topical Solution is contraindicated in those individuals who have shown hypersensitivity to any of its components.
Erythromycin Topical Solution USP, 2% is a clear, colorless liquid, which is supplied as follows: 60 mL bottle with applicator NDC 52565-027-59 Store at 20° to 25°C (68° to 77°F); excursions permitted between 15° to 30°C (59° to 86° F) [See USP Controlled Room Temperature]. Manufactured by: Teligent Pharma, Inc. Buena, New Jersey 08310 Rev 07/16
Abbreviated New Drug Application
ERYTHROMYCIN - ERYTHROMYCIN SOLUTION TELIGENT PHARMA, INC. ---------- ERYTHROMYCIN TOPICAL SOLUTION USP 2% FOR TOPICAL USE ONLY. NOT FOR USE IN EYES. DESCRIPTION: Erythromycin Topical Solution contains erythromycin for topical dermatologic use. Erythromycin is a macrolide antibiotic produced from a strain of _Saccaropolyspora erythraea_ (formerly _Streptomyces_ _erythreus_). It is a base and readily forms salts with acids. Chemically, erythromycin is: (3_R_*,4_S_*,5_S_*,6_R_*,7_R_*,9_R_*,11_R_*, 12_R_*,13_S_*,14_R_*)-4-[(2,6-Dideoxy-3-_C_- methyl-3-_O_-methyl-α_-_L-_ribo_- hexopyranosyl)-oxy]-14-ethyl-7,12,13-trihydroxy-3,5,7,9,11,13-hexamethyl-6-[[3,4,6-trideoxy-3- (dimethylamino)-β-D-_xylo_-hexopyranosyl]oxy]oxacyclotetradecane-2,10-dione. It has the following structural formula: Erythromycin is a white or slightly yellow crystalline powder that is very soluble in water, freely soluble in alcohols, acetone, chloroform, acetonitrile, ethyl acetate, and moderately soluble in ether, ethylene dichloride and amyl acetate. Each mL of Erythromycin Topical Solution USP 2% contains 20 mg of erythromycin base in a vehicle consisting of alcohol (71.5%), propylene glycol, and citric acid. CLINICAL PHARMACOLOGY: The exact mechanism by which erythromycin reduces lesions of acne vulgaris is not fully known; however, the effect appears to be due in part to the antibacterial activity of the drug. MICROBIOLOGY: Erythromycin acts by inhibition of protein synthesis in susceptible organisms by reversibly binding to 50 S ribosomal subunits, thereby inhibiting translocation of aminoacyl transfer- RNA and inhibiting polypeptide synthesis. Antagonism has been demonstrated _in vitro_ between erythromycin, lincomycin, chloramphenicol, and clindamycin. INDICATIONS AND USAGE: Erythromycin Topical Solution is indicated for the topical treatment of acne vulgaris. CONTRAINDICATIONS: Erythromycin Topical Solution is contraindicated in those individuals who have shown hypersensitivity to any of its components. WARNINGS: PSEUDOMEMBRANOUS COLIT Прочетете целия документ